You have no items in your shopping cart.
You have no items in your shopping cart.
| Catalog Number | orb1239079 |
|---|---|
| Category | Antibodies |
| Description | SARS-CoV-2 (COVID-19) NSP13 (Helicase) Antibody |
| Target | HEL |
| Clonality | Polyclonal |
| Isotype | IgG |
| Conjugation | Unconjugated |
| Reactivity | Virus |
| Form/Appearance | Liquid |
| Concentration | 1 mg/mL |
| Buffer/Preservatives | SARS-CoV-2 (COVID-19) NSP13 (Helicase) Antibody is supplied in PBS containing 0.02% sodium azide. |
| Purification | SARS-CoV-2 (COVID-19) NSP13 (Helicase) Antibody is affinity chromatography purified via peptide column. |
| Immunogen | Anti-SARS-CoV-2 (COVID-19) NSP13 (Helicase) antibody (orb1239079) was raised against a peptide corresponding to 19 amino acids near the carboxyl terminus of the SARS-CoV-2 (COVID-19) NSP13 (Helicase) protein. The immunogen is located in the last 50 amino acids of SARS-CoV-2 (COVID-19) NSP13 (Helicase). |
| UniProt ID | P0DTC1 |
| Tested applications | ELISA, IHC |
| Antibody Type | Primary Antibody |
| Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
| Alternative names | Helicase, Non-structural protein 13, NSP13 |
| Research Area | Infectious Disease & Virology |
| Note | For research use only |
| NCBI | YP_009725308.1 |
| Expiration Date | 12 months from date of receipt. |

Immunohistochemistry Validation of SARS-CoV-2 (COVID-19) NSP13 in COVID-19 Patient Lung. Immunohistochemical analysis of paraffin-embedded COVID-19 patient lung tissue using anti-SARS-CoV-2 (COVID-19) NSP13 antibody (orb1239079, 0.5 µg/mL). Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4 ˚C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin. Strong signal of SARS-COV-2 NSP13 protein was observed in macrophage of COVID-19 patient lung, but not in non-COVID-19 patient lung.

ELISA Validation with SARS-CoV-2 (COVID-19) NSP13 (Helicase) Protein. Antibodies: SARS-CoV-2 (COVID-19) NSP13 (Helicase) Antibody, orb1239079. A direct ELISA was performed using SARS-CoV-2 NSP13 recombinant protein (orb1231563) as coating antigen and the anti-SARS-CoV-2 (COVID-19) NSP13 (Helicase) antibody as the capture antibody. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:20000 dilution. Detection range is from 1 ng/mL to 3000 ng/mL.

ELISA Validation. Antibodies: SARS-CoV-2 (COVID-19) NSP13 (Helicase) Antibody, orb1239079. A direct ELISA was performed using immunogen peptide (orb1231680) as coating antigen and the anti-SARS-CoV-2 (COVID-19) NSP13 (Helicase) antibody as the capture antibody. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:20000 dilution. Detection range is from 0.3 ng/mL to 1000 ng/mL.
ELISA, IHC | |
Virus | |
Polyclonal | |
Unconjugated |
ELISA | |
Virus | |
Polyclonal | |
Unconjugated |
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review